Grail CEO and CFO Execute Hundreds of Thousands in Stock Sales

Executives at biotech company Grail have sold substantial portions of their personal holdings, with the chief executive and chief financial officer offloading shares worth over a million dollars combined. The transactions follow standard pre-planned trading schedules and do not necessarily indicate internal concerns about the company’s outlook.